Tirzepatide in India
CDSCO-approved as Mounjaro since March 2025, with Eli Lilly's published vial pricing creating real arbitrage vs Western markets. Premium private hospital chains (Apollo, Fortis, Manipal) anchor the legitimate route; CDSCO has issued misuse advisories on grey-market GLP-1 sales so the hospital channel matters more than usual here.
CDSCO-registered as Mounjaro (Eli Lilly) since March 2025 for type 2 diabetes. Off-label weight prescribing legal under Indian medical practice rules. Prescription-only. CDSCO has issued public advisories on GLP-1 misuse — hospital channel is the trustworthy lane.
What it actually costs.
Midpoint ranges, Eli Lilly brand unless noted. Updated April 2026.
Per month at typical 5-10 mg dose. Eli Lilly's published price ₹3,500/2.5mg vial / ₹4,375/5mg vial. Apollo Pharmacy stocks; hospital prescription required.
Per month including endo consult + bloodwork. NABH/JCI-accredited chains.
Per month. Smaller chains in non-metro cities; supply less consistent than the big-three.
How to get it — on the right side of the line.
Apollo Hospitals + Apollo Pharmacy
Most mature route: Apollo Hospitals endocrinology consult + Apollo Pharmacy fulfillment. Apollo Pharmacy publishes a 'How to Buy Wegovy in India' guide and a Mounjaro stock page. 70+ hospital sites, English-fluent international-patient ops.
Fortis Healthcare or Manipal Hospitals
Fortis Vasant Kunj (Delhi) has a dedicated Obesity Clinic; Fortis C-DOC is a Centre of Excellence for Diabetes & Endocrinology. Manipal has city-specific Weight & Metabolic Health clinics, particularly Bangalore.
Direct retail at Apollo Pharmacy
With a hospital prescription, Apollo Pharmacy retail purchase at the published Lilly price. The cheapest legitimate route in India and one of the cheapest globally.
What channels actually work here.
Apollo / Fortis / Manipal nationwide; Mounjaro since March 2025.
Compounded GLP-1 is a CDSCO-flagged grey-market segment; Panya does not route there.
CDSCO advisories active. Not recommended.
Apollo + Manipal both run telehealth + in-person hybrid.
India has the cheapest legitimate Mounjaro pricing of any country with Lilly's official channel. ₹3,500 per 2.5mg vial is ~$42 USD, vs ~$1,000+/month US cash-pay. For travel-resident or medical-tourism patients, the Apollo route is hard to beat. Confirm hospital stock at intake — supply has been consistent since the March 2025 launch but tier-2 chains see gaps.
What's actually in stock right now.
Per-brand stock state for tirzepatide in this region, sourced from cohort research and operator feedback. Each entry has a verifiedAt date so you can judge freshness. Confirm at the specific provider before booking.
Eli Lilly published price ladder ₹3,500/2.5mg vial (~₹14k–17.5k/month). Apollo Pharmacy + hospital prescription. Supply consistent since the March 2025 launch.
Semaglutide in India
Ozempic / Wegovy / Rybelsus — GLP-1-only agonist. Novo Nordisk. Longer brand history, slightly cheaper, more reliably stocked in 2026 than tirzepatide in most markets. Rybelsus oral exists for needle-averse patients.
Match me to a vendor in India.
Two minutes, five questions. Your match email has the vendor name, price, and the honest tradeoff.
We earn a small commission when you buy through recommended vendors. That is how this stays free. Vendors rank by quality signals, not paid placement.